Soluble guanylate cyclase modulators-a novel therapeutic approach for diabetic kidney disease. [PDF]
Xu Y +8 more
europepmc +1 more source
Hemoglobin resident in the lung epithelium is protective for smooth muscle soluble guanylate cyclase function. [PDF]
Sumi MP +7 more
europepmc +1 more source
Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm. [PDF]
Muminovic A, Chirkov YY, Horowitz JD.
europepmc +1 more source
The Novel Soluble Guanylate Cyclase Stimulator Attenuates Acute Lung Injury via Inhibiting Pericyte Phenotypic Transition. [PDF]
Huang YL +12 more
europepmc +1 more source
Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolution. [PDF]
Balzer MS +11 more
europepmc +1 more source
The inhibition of soluble guanylate cyclase (sGC) by canthin-6-one alkaloid (L1) is presented and the mechanism of deactivation is studied using solution phase and voltammetry of microparticles methodologies.
Cebrian-Torrejon, G. +6 more
core
Endothelial soluble guanylate cyclase enzyme inhibitors as a novel target for the treatment of sepsis-related hypotension. [PDF]
Suleiman YAA, Khalil AMM, Almofti YA.
europepmc +1 more source
Soluble Guanylate Cyclase Stimulators in Heart Failure. [PDF]
Kansakar S +7 more
europepmc +1 more source
Synergistic Cardiopulmonary Protection of Endothelin Receptor Antagonists Combined With Soluble Guanylate Cyclase Agonists in High-Risk Coronary Syndrome With Pulmonary Hypertension. [PDF]
Zhao L, Pang X.
europepmc +1 more source
Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy. [PDF]
Hu BA +11 more
europepmc +1 more source

